B-MICS with INCISE IOL implantation through 1.4 mm clear corneal incisions: 18 months follow-up and PCO evaluation

Session Details

Session Title: PCO. Cataract Surgery Complications/Management

Session Date/Time: Tuesday 08/09/2015 | 08:00-10:30

Paper Time: 08:52

Venue: Room 1

First Author: : G.Torlai ITALY

Co Author(s): :    L. Campi   C. Benatti   E. Volpini   C. Peppoloni   G. Cavallini        

Abstract Details

Purpose:

To analyze the visual outcomes and the posterior capsule opacification (PCO) of the INCISE MJ14 IOL implanted through 1.4 mm clear corneal incision (CCI) in patients who underwent bimanual microincisions cataract surgery (B-MICS).

Setting:

Institute of Ophthalmology, University of Modena & Reggio Emilia, Modena, Italy (Head: Prof. Gian Maria Cavallini).

Methods:

Prospective study. To compare 30 eyes which underwent B-MICS and implanted with INCISE MJ14 IOL through 1.4 mm CCI (group A) with 30 eyes which underwent B-MICS and implanted with Akreos MI60 IOL through 1.5 mm CCI (group B). All patients underwent uneventful bimanual-MICS cataract surgery. PCO has been evaluated with EPCO 2000 Incl. Merge (Creative Development, CA) at 6 and 18 months after surgery. The CCIs have been examined through an anterior segment OCT (AS-OCT) and slit lamp camera at 1, 3, 7 and 30 days and 6 months after surgery. All clinical parameters have been reported and analyzed.

Results:

CDVA and mean endothelial cell density achieved optimal outcomes in both the groups. PCO evaluation showed no growth of epithelial cell lens in any portion of the IOL optic plate at 18 months of follow-up. Rare opacities have been reported at the edge of the IOL with no sign of optic plate invasion. At the AS-OCT the only common evidences in the CCIs were endothelial gaping and local detachment of Descemet's membrane with reduction in the first week of the follow-up. No evidence of any morphological alterations has been reported at the AS-OCT examination at 18 months of follow-up.

Conclusions:

The implant of an MJ14 INCISE IOL through 1.4 mm CCI with B-MICS technique appeared to be safe and effective with a rapid visual recovery and a high patients' satisfaction. Thanks to this new IOL innovative design characterized by a 5 microns, 360° square edge, the PCO scoring in the first 18 months after this IOL release, appear to be encouraging, confirming the aim of minimizing PCO in the long term. The incisions achieve a fast healing since the first week of follow-up and only temporary morphological alterations were detectable through anterior segment imaging.

Financial Interest:

NONE